Josef Schwarz - Proteome Sciences Insider

Proteome Sciences plc -- UK Stock  

GBp 3.71  0.05  1.33%

Head of Projects and Production - Proteome Sciences RandD

Dr. Josef Schwarz is Head Projects Production, Proteome Sciences RD of Proteome Sciences PLC. Joseph Schwarz joined the Group in summer 2002 when Xzillion, the former proteomics division of Aventis Research and Technologies, was acquired by Proteome Sciences plc. He worked for AventisHoechst Research and Technologies for 6 years, initially as head of mass spectrometry and later as research collaboration project leader. He was instrumental in the establishment of the integrated high throughput 2DEmass spectrometry proteomics platform at the Frankfurt research facility. Josef Schwarz holds a PhD in organic chemistrymass spectrometry from the Technical University of Berlin, Germany and a MBA from the University of Durham, UK. He is an author of a number of publications and coinventor of patents.
  Executive Since 2011  MBA    
44 20 7043 2116  http://www.proteomics.com

Management Efficiency

The company has return on total asset (ROA) of (20.17) % which means that it has lost $20.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (16.4) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8.93 M in total debt. Proteome Sciences plc has Current Ratio of 0.38 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Found 6 records

EXECUTIVE Since

Paul MussendenBTG plc
2010
Hussein ArkhaghaHikma Pharmaceuticals PLC
2013
Peter SpeirsHikma Pharmaceuticals PLC
2012
Bassam KanaanHikma Pharmaceuticals PLC
2014
Simon ThornRedx Pharma Plc
N/A
Tony BunnSareum Holdings plc
N/A

Entity Summary

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Medical Laboratories Research classification in UK and traded on London Stock Exchange. It employs 36 people.Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 36 people.

Proteome Sciences plc Leadership Team

William Dawson, Director
Roger McDowell, Director
Christopher Pearce, Director
Ian Pike, Director, Ph.D
Richard Dennis, Executive
Malcolm Ward, Executive
Martin Diggle, Director
Jeremy Haigh, CEO
Josef Schwarz, Executive, MBA
Ursula Ney, Director, Ph.D
Glenn Barney, VP
Gee Chee, Director, Ph.D
Geoffrey Ellis, Director

Stock Performance Indicators

Did you try this?

Run Fundamentals Matrix Now
   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
View All  Next Launch Fundamentals Matrix

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
a day ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
a day ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
a day ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
a day ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
a day ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
a day ago
Traded for 23.82
Additionally take a look at Your Equity Center. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.